Elizabeth Swisher is an Oncology physician affiliated with University of Washington. OpenAlex indexes 750 publications with 67,750 citations (h-index 103); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Gynecologic Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Seattle Cancer Care Alliance
825 Eastlake Avenue East
Seattle, WA 98109
Telephone
206-288-7400Registry record last updated 7 Jun 2011.
Clinical trials
- Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Sponsor: University of Washington
- Early Detection of GEnetic Risk (EDGE)
Sponsor: University of Washington
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Clovis Oncology, Inc.Program year20214 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Proton pump inhibitor100%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 2002–2026 per NIH RePORTER. The latest:
- Clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancer
University of Washington
FY2026$648,957R01CA272594 - Clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancer
University of Washington
FY2025$648,957R01CA272594 - Clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancer
University of Washington
FY2024$616,508R01CA272594
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
Nature Communications
2020 - Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
New England Journal of Medicine
2019
Similar KOLs
Other experts from the same institution or the same specialty.
David Tirschwell
University of Washington
Connie Celum, MD, MPH
University of Washington
Helen Chu, MD, MPH
University of Washington
Bryan Kestenbaum, MD
University of Washington
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”